Matthew B. Klein

Chief Executive Officer, Director, Ptc Therapeutics, Inc.; Director, ClearPoint Neuro, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$4.4M

Companies

Latest trade

Aug 4, 2026

Companies

Ptc Therapeutics, Inc.Chief Executive Officer, Director −$4.2M ClearPoint Neuro, Inc.Director −$0.2M

Trades

PTCT Sold 10,292 shares at $68.57 · planned $0.7M Aug 4

CLPT Sold 16,000 shares at $11.59 $0.2M May 21

PTCT Sold 12,572 shares at $72.95 · planned $0.9M May 14

PTCT Sold 2,850 shares at $70.91 · planned $0.2M Apr 21

PTCT Sold 2,662 shares at $64.08 · planned $0.2M Mar 12

PTCT Sold 7,371 shares at $69.36 · planned $0.5M Feb 18

PTCT Sold 2,514 shares at $76.45 · planned $0.2M Jan 8

PTCT Sold 3,016 shares at $77.48 · planned $0.2M Jan 7

PTCT Sold 5,149 shares at $76.95 · planned $0.4M Jan 6

PTCT Sold 8,089 shares at $76.64 · planned $0.6M Dec 30

PTCT Sold 3,428 shares at $79.07 · planned $0.3M Dec 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.